Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Intermediate-Sized Expanded Access Study
- Conditions
- Amyotrophic Lateral Sclerosis
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Seelos Therapeutics, Inc.
- Registration Number
- NCT05597436
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Seelos Therapeutics, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT05490563
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸UCHealth Neurosciences Center - Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸University of South Florida, Tampa, Florida, United States
SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: SLS-005 - Twice WeeklyDrug: SLS-005 - Once Weekly
- First Posted Date
- 2022-04-18
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Seelos Therapeutics, Inc.
- Registration Number
- NCT05332678
- Locations
- 🇦🇺
Austin Health, Heidelberg, Victoria, Australia
🇦🇺Goulburn Valley Health, Shepparton, Victoria, Australia
🇦🇺Neurodegenerative Disorders Research Pty Ltd, West Perth, Western Australia, Australia
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
- Conditions
- Depressive Disorder, MajorSuicidal
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Seelos Therapeutics, Inc.
- Target Recruit Count
- 164
- Registration Number
- NCT04669665
- Locations
- 🇺🇸
Seelos Investigational Site, Morgantown, West Virginia, United States